We support our Publishers and Content Creators. You can view this story on their website by CLICKING HERE.
Subscribe to Louder with Crowder on Rumble! Download the app on Apple and Google Play.
Mug Club Undercover released PART 2 of VarmaGate today after SIGA Technologies fired NYC Covid czar Dr. Jay Varma for comments he made regarding sex parties in defiance of his own COVID protocols.
On September 23, the Board of Directors of SIGA Technologies fired Varma.
Media outlets have been claiming that monkeypox “is coming back deadlier than before” and that the powers that be “must curb this threat before it once again wreaks havoc around the world.” However, according to Varma, the risk is very low and it’s “only transmitted among gay men.”
“If you are going to deal with a problem, you need to be accurate in assessing. That’s the problem with cancel culture and political correctness,” Crowder said.
Varma worked for SIGA and was hired to sell TPOXX, a smallpox medication the company hopes the government will use to treat Monkeypox.
“We want the Food and Drug Administration, the FDA, to approve our drug, especially for Monkeypox and right now it’s only considered experimental and they won’t approve it based on the study,” Varma claimed in the undercover footage. “The problem is the study was designed to be for all patients. It should have been designed to study for people who come in really early.”
He added that the drug looks like it works but that “the people they need to buy it are not going to be as confident in it because the data does not look as strong as it would if we designed it a different way.”
In other words, he claims they should have designed” the study in “a different way” because it turns out that proper wound care and adequate nutrition had the same improvements as TPOXX.
“That means the only way you could design this study to prove the efficacy of the drug would be to keep half of the patients starving and not in a facility practicing basic hygiene and wound care,” Crowder said.
He also claims he has a good relationship with many media outlets and that they need to keep up the impression the drug works, which is why the media spinning it in their favor is helpful.
“We are trying to get the media to say the drug didn’t work because it was designed the wrong way and they are going to do another study and it’ll probably work,” Varma added, emphasizing this is how they can push emergency use authorization.
“It’s not about helping you because that can be done with measures you could do yourself,” Crowder said. “If you feel like your representation does not represent you, you are not crazy.”